Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

Navigating the Atopic Dermatitis Landscape: From Diagnosis to Tailored Treatment Plans : Episode 2

Opinion

Video

July 8, 2024

Optimizing Management of Atopic Dermatitis and Alopecia Areata: From First-Line to Second-Line Treatments and Safety Protocols

Author(s):

Robert Bruce Posnick, MD, examines a case of a 55-year-old female patient with a 50-year history of atopic dermatitis, comorbid asthma, and severe alopecia areata, presenting with recurrent patches throughout her body, predominantly affecting her face, hands, trunk, arms, legs, and eyelids.

EP: 1.Advances in Atopic Dermatitis Management: A Comprehensive Approach to Treatment and Skin of Color Considerations

Now Viewing

EP: 2.Optimizing Management of Atopic Dermatitis and Alopecia Areata: From First-Line to Second-Line Treatments and Safety Protocols

EP: 3.Clinical Insights Into Challenging Atopic Dermatitis Cases: Part 3

What is your impression of this case? What challenges does this case present with, if any?
What co-morbidities do you typically see with Atopic Dermatitis?
Given her history, would you treat systemically? If so, oral JAK or injectable biologic?
Would you consider a topical JAK, ie ruxolitinib? If so, any concern using topical JAK in combo with systemic therapy, if so which ones?

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!